Anti-tumor effects for solid tumors in digestive tracts were produced by a chimeric type of oncolytic adenoviruses and the carrier cells
Project/Area Number |
21590879
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | Chiba Cancer Center (Research Institute) |
Principal Investigator |
KAWAMURA Kiyoko 千葉県がんセンター(研究所), がん治療開発グループ, 上席研究員 (80260248)
|
Co-Investigator(Kenkyū-buntansha) |
TAGAWA Masatoshi 千葉県がんセンター, がん治療開発グループ, 部長 (20171572)
YAMAGUCHI Taketo 千葉県がんセンター, 医療局, 診療部長 (00241969)
|
Project Period (FY) |
2009 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2011: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2010: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2009: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | 膵臓癌 / アデノウイルス / 細胞死 / がん治療 / 膵がん / 遺伝子医薬 / アポトーシス / オートファジー / cytopathic effect / p53 / アデノイルス / G2/M期 / 細胞周期 / 転写調節 / 抗がん剤 / 塩酸ゲムシタビン / ペメトレキセド / Geldanamycin |
Research Abstract |
It is difficult to effectively treat patients with an extended tumor in the digestive tract in particular those who become refractory to standard chemotherapy. We thereby examined a possible anti-tumor effects produced by replication-competent adenoviruses that preferentially proliferate within the target tumors. We also modified the receptor-binding portion to facilitate the infectivity. The anti-tumor effects were also achieved with the adenovirally transduced cells.
|
Report
(4 results)
Research Products
(13 results)
-
[Journal Article] Upregulated p53 expression activates apoptotic pathways in wild-type p53-bearing mesothelioma and enhances cytotoxicity of cisplatin and pemetrexed2012
Author(s)
Li, Q., Kawamura, K., Okamoto, S., Yamanaka, M., Yang, S., Yamauchi, S., Fukamachi, T., Kobayashi, H., Tada, Y., Takiguchi, Y., Tatsumi, K., Shimada, H., Hiroshima, K. and Tagawa, M.
-
Journal Title
Cancer Gene Ther
Volume: 19
Issue: 3
Pages: 218-228
DOI
Related Report
Peer Reviewed
-
[Journal Article] A possible anti-cancer agent, type III interferon, activates cell death pathways and produces anti-tumor effects2011
Author(s)
Tagawa, M., Kawamura, K., Li, Q., Tada, Y., Hiroshima, K. and Shimada, H.
-
Journal Title
Clin. Dev. Immunol
Volume: 2011
Pages: 1-6
DOI
Related Report
Peer Reviewed
-
[Journal Article] Adenoviruses-mediated transduction of human esophageal carcinoma cells with the interferon-lambda genes produced anti-tumor effects2011
Author(s)
Li, Q., Kawamura, K., Okamoto, S., Fujie, H., Numasaki, M., Namba, M., Nagata, M., Shimada, H., Kobayashi, H. and Tagawa, M.
-
Journal Title
Br. J. Cancer
Volume: 105
Issue: 9
Pages: 1302-1312
DOI
Related Report
Peer Reviewed
-
[Journal Article] Tumor specific low pH environment enhance the cytotoxicity of lovastatin and cantharidin2010
Author(s)
Fukamachi, T., Chiba, Y., Wang, X., Saito, H., Tagawa, M. and Kobayashi, H.
-
Journal Title
Cancer Lett
Volume: 297
Issue: 2
Pages: 182-189
DOI
Related Report
Peer Reviewed
-
[Journal Article] Combinatory cytotoxic effects produced by E1B-55kDa-deleted adenoviruses and chemotherapeutic agents are dependent on the agents in esophageal carcinoma2010
Author(s)
Ma, G., Kawamura, K., Li, Q., Okamoto, S., Suzuki, N., Kobayashi, H., Liang, M., Tada, Y., Tatsumi, K., Hiroshima, K., Shimada, H. and Tagawa, M.
-
Journal Title
Cancer Gene Ther
Volume: 17
Issue: 11
Pages: 803-813
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] Cytotoxicity of adenoviruses expressing the wild-type p53 gene to esophageal carcinoma cells is linked with the CAR expression level and indirectly with the endogenous p53 status2009
Author(s)
Ma, G., Kawamura, K., Li, Q., Suzuki, N., Liang, M., Namba, M., Shimada, H. and Tagawa, M.
-
Journal Title
Cancer Gene Ther
Volume: 16
Issue: 11
Pages: 832-840
DOI
Related Report
Peer Reviewed
-
-
-
-
-